BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Overview Fund Activity
Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

27 hedge funds and large institutions have $3.94M invested in BRAINSTORM CELL THERAPUTC in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Holders
27
Holders Change
+3
Holders Change %
+12.5%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
3
Closed
3
Calls
$18K
Puts
$8K
Net Calls
+$10K
Net Calls Change
+$104K

Top Buyers

1
PA
1
Perceptive Advisors
New York
$1.02M
2
VKH
2
Virtu KCG Holdings
New York
$101K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.48M
4
SEI Investments
4
SEI Investments
Pennsylvania
$16K
5
Bank of America
5
Bank of America
North Carolina
$38K

Top Sellers

1
SM
1
Sabby Management
Florida
$637K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$0
3
GCA
3
Guardian Capital Advisors
Ontario, Canada
$0
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$6K
5
TWA
5
TCI Wealth Advisors
Arizona
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
US Bancorp
26
US Bancorp
Minnesota
$1K – – –
Citigroup
27
Citigroup
New York
$1K – – –
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
– -$51K -1,427 Closed
GCA
29
Guardian Capital Advisors
Ontario, Canada
– -$24K -667 Closed
TWA
30
TCI Wealth Advisors
Arizona
– -$3K -73 Closed
1
2